Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Pharmacogenet Genomics. 2012 Feb;22(2):95–104. doi: 10.1097/FPC.0b013e32834dc9ef

Table 1.

Clinical Characteristics of Study Subjects

Clinical Characteristics Gender NG Controls
n=1,124
595 M/529 F
T2D Cases
n=1,307
682 M/625 F
p values
Age (yr) M 51.3±15.2 55.6±11.4 6.1×10−10
F 50.2±13.4 55.3±10.9 7.9×10−11
Age at Diagnosis (yr) M -- 46.9±11.2 --
F -- 48.4±10.9 --
Duration of Diabetes (yr) M -- 8.3±7.2 --
F -- 7.0±6.3 --
Systolic Blood Pressure (mmHg) M 136.0±22.1 147.7±22.5 2.82×10−18
F 135.2±24.3 148.1±24.4 1.50×10−17
Diastolic Blood Pressure (mmHg) M 82.1±13.0 85.7±12.5 1.21×10−6
F 81.0±12.5 84.9±11.7 1.47×10−7
BMI (kg/m2) M 25.7±4.6 26.5±4.4 0.002
F 26.9±5.8 28.2±5.45 0.001
HDL-C (mg/dL) M 35.7±15.1 34.3±12.4 0.083
F 41.0±15.3 38.3±12.9 0.007
LDL-C (mg/dL) M 97.4±36.8 94.6±38.0 0.422
F 105.1±36.4 106.3±35.9 0.077
Fasting Blood Glucose (mg/dL) M 94.3±12.7 162.2±60.9 1.8×10−74
F 94.3±12.9 163.3±64.0 1.5×10−59
Total Cholesterol (mg/dL) M 165.1±55.9 167.1±47.4 0.705
F 181.6±49.2 182.1±48.1 0.093
Triglycerides (mg/dL) M 150.5±74.9 156.0±83.2 0.021
F 145.2±68.5 160.1±84.5 0.015
CETP Activity (pmoles/200 µL) M 195.6±32.0 189.5±33.6 0.186
F 193.2±33.1 206.0±29.4 0.004
CAD (%) 11.4 16.9
Alcohol Consumption (%)
No Alcohol M 72 57 --
F 100 100 --
Moderate M 22 33 --
F 0 0 --
High M 6 10 --
F 0 0 --

CAD-Coronary Artery Disease